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Background. The impact of echocardiographic-guided treat-
ment on outcome after tricuspid valve (TV) surgery is not well
defined.
Objectives. The purpose of this study was to determine clinical
and echocardiographic factors associated with adverse outcomes
after TV surgery and determine the role of intraoperative echo
(IOE) in facilitating successful outcomes after TV surgery.
Methods. Four hundred and one patients (279 females, mean
age 60 years) underwent TV surgery and other concomitant
cardiac surgery at a single institution and were followed clinically
and by echocardiography during a 10-year period.
Results. Decreased survival after TV surgery was associated
with: preoperative increased New York Heart Association (NYHA)
functional classification (relative risk [RR] 5 2.02), increased left
ventricular dysfunction by echocardiography (RR 5 1.28), and
use of a TV replacement strategy (RR 5 2.92). Decreased event-
free survival after TV surgery was associated with concomitant
coronary artery bypass grafting (RR 5 2.97). Late echocardio-
graphic failure (3 to 41 tricuspid valve regurgitation [TR]) after
TV surgery was associated with increased severity of TR on
preoperative echocardiogram (odds ratio [OR] 5 1.91). De-
creased late echocardiographic failure after TV surgery was
associated with the use of a TV annuloplasty ring with a repair
strategy (OR 5 0.40). The surgical plan was altered at the time of
surgery to insure a successful outcome in 32 (10%) of 335 patients
based on IOE findings.
Conclusions. Adverse outcomes after TV surgery can be pre-
dicted by several preoperative clinical and echocardiographic
variables. IOE is useful in improving immediate, but not late,
outcomes after TV surgery.
(J Am Coll Cardiol 1998;32:1023–31)
©1998 by the American College of Cardiology
Clinical risk factors associated with increased mortality after
surgery to correct a dysfunctional tricuspid valve (TV) include:
the presence of coronary artery disease (1–3), increased New
York Heart Association (NYHA) functional class (1–8), a
history of prior cardiac surgery (4,9), the presence of signs and
symptoms of congestive heart failure (1,5,7,9), the presence of
signs and symptoms of significant primary pulmonary disease
(1,10), and male gender (5,7,9).
Echocardiography has developed into an indispensable
adjunct to the clinical interview and physical examination for
preoperative and postoperative evaluation of cardiac patho-
physiology in the setting of valvular heart disease. The use of
intraoperative echocardiography (IOE) is beneficial in insuring
a successful immediate outcome after cardiac valvular surgery
(11–19). Evidence of such benefit is most compelling with the
use of IOE in the surgical repair of the dysfunctional mitral
valve (20). Evidence of the benefit of the use of IOE in the
surgical repair of the dysfunctional TV (12–19) is limited by a
smaller number of patients evaluated in fewer studies com-
pared with mitral valve surgery. No prior study has specifically
examined what association exists, if any, between preoperative
and intraoperative echocardiographic findings and the clinical
and echocardiographic outcomes after TV surgery. The pur-
pose of this study was to determine which of several preoper-
ative and intraoperative clinical and echocardiographic factors
are associated with adverse clinical and echocardiographic
outcomes after TV surgery. A secondary purpose of this large
cohort study was to demonstrate the benefit, if any, of the use
of IOE on both the clinical and echocardiographic outcomes of
TV surgery.
Methods
Study population. The study population consisted of 401
patients who underwent initial TV surgery, with and without
other concomitant surgical procedures, over a 10-year period
at a single tertiary referral center (The Cleveland Clinic
Foundation), and had complete preoperative and follow-up
echocardiograms. The study population excluded patients who
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had no preoperative or follow-up echocardiogram, and was
divided into two groups for the purpose of comparison, as
depicted in Figure 1. The use of IOE was based on availability
of echocardiographic equipment and the individual surgeon’s
preference.
Echocardiographic criteria for severity of tricuspid regur-
gitation. The severity of tricuspid regurgitation (TR) was
assessed semi-quantitatively using pulsed-wave Doppler (21–
24) and/or contrast (25–27) and/or color (18,28) Doppler flow
mapping of the spatial distribution of the regurgitant jet within
the right atrium. The dimensions and/or area of the regurgitant
jet were compared with the right atrial dimensions and/or area
in several planes, and the comparison was translated to a
semi-quantitative (0 to 41) grading scale (18,22,28–30) corre-
sponding to no, mild, moderate, moderately severe, and severe
regurgitation, respectively.
Echocardiographic criteria for severity of ventricular dys-
function. Global measurements of left ventricular systolic
function were made using accepted systolic indices of the
dimensions or volume of the left ventricular chamber (31).
Global measurements of right ventricular systolic function
were made using the excursion of the tricuspid annulus in
systole in an apical four-chamber view (32). Less frequently,
contrast echocardiography was used to obtain a measure of
right ventricular ejection fraction (33,34). The obtained mea-
surements were routinely translated to a semi-quantitative,
five-category grading scale corresponding to normal, mild,
moderate, moderately severe, and severe ventricular dysfunc-
tion, respectively.
Preoperative and follow-up echocardiographic assessment.
Preoperative two-dimensional and Doppler flow echocardiog-
raphy was performed with either a transthoracic (92%) or
transesophageal (2%) transducer, or both (6%), to optimize
the imaging and Doppler data obtained. Several commercially
available echocardiographic systems (Hewlett-Packard; Acu-
son) were used during the study period. Color Doppler gain
controls were adjusted to obtain a barely perceptible amount
of background color “speckle” in the far field. Evaluation of
TR was performed as described using multiple imaging planes.
Echocardiographic studies were recorded on high-fidelity VHS
tape for replay review and archival storage. Clinical interpre-
tation reports, based on a consensus of at least two experi-
enced echocardiographers, were generated based on findings
read on the echocardiogram using real-time review or replay
review, or both.
Intraoperative echocardiographic assessment. Intraopera-
tive echocardiography was performed with either an epicardial
(14.5%) or a transesophageal transducer (72%), or both
(13.5%), to optimize the imaging and Doppler data obtained.
Both epicardial and transesophageal echocardiograms were
performed according to standard published and accepted
techniques (11,12,35,36). Initial imaging was performed after
endotracheal intubation and induction of general anesthesia,
but before instituting cardiopulmonary bypass. Subsequent
imaging was obtained during the operation as warranted and at
the completion of the surgical procedure after removal of
cardiopulmonary bypass support and stabilization of hemody-
namics. Multiple imaging planes were used for Doppler map-
ping of TR, including a four-chamber view. The severity of TR
was analyzed and graded online by an experienced echocardi-
ographer with transducer in hand.
Intraoperative surgical assessment. Annuloplasty tech-
niques not assessed with IOE were assessed using accepted
surgical techniques of insufflation and/or digital exploration of
the right atrial cavity to detect and grade the severity of any
residual TR (37,38). Appropriate surgical adjustment could
then be performed to minimize TR detected by these methods.
Figure 1. Diagram of the patient population demonstrating the use of
preoperative, intraoperative, and postoperative echocardiography.
Abbreviations and Acronyms
IOE 5 intraoperative echocardiogram or intraoperative
echocardiography
NYHA 5 New York Heart Association
OR 5 odds ratio
RR 5 relative risk
TR 5 tricuspid valve regurgitation
TV 5 tricuspid valve
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However, DeVega’s sliding annuloplasty (39) was infrequently
performed. A suture annuloplasty was routinely performed
based on the size of the fibrous portion of the tricuspid annulus
and the size of the septal leaflet of the TV.
Echocardiographic criteria for tricuspid valve repair fail-
ure. Echocardiographic failure of TV surgery was designated
as a postoperative echocardiographic study demonstrating
grade 31 or 41 TR. If the postcardiopulmonary bypass
intraoperative echocardiographic study demonstrated TV re-
pair failure, the patient had, at the echocardiographer’s rec-
ommendation and the surgeon’s discretion, a second cardio-
pulmonary bypass run to correct the residual regurgitation
during the same thoracotomy (Fig. 2).
Clinical data. Clinical data were abstracted from review of
patient charts, regular follow-up of patients using mail surveys
and telephone interviews, and communications with referring
physicians. Pulmonary disease was defined in this study as the
presence of any one of the following established diagnoses:
chronic obstructive lung disease, other chronic lung disease, or
history of pulmonary embolus.
Adverse clinical events criteria. Four adverse clinical
events pertinent to the study purpose were tracked in
follow-up and included: death, recurrence of any number of
the constellation of symptoms that prompted the initial TV
surgery, the occurrence of any number of cardinal symptoms
attributed to congestive heart failure, and any combination of
the above symptoms, along with an echocardiographic assess-
ment of TV repair failure that led to a second TV surgery.
Adverse clinical events were closely tracked and formally
updated by patient contact on an every-other-year basis for
each patient as part of the designed operation and mainte-
nance of a surgical valve registry.
Statistics. Categorical and ordinal data were compared
using a chi-square test to ascertain an overall p value, and then
the two groups were compared at each level (40). Continuous
variables with a normal distribution were compared using the
t test. Non-normally distributed continuous data were com-
pared using Wilcoxon rank sum test. The Kaplan-Meier
method was used to compute survival statistics, and the
log-rank statistic was used to compare the survival curves. The
0.05 significance level was used to determine statistical signif-
icance for all comparisons.
Cox regression was used to determine risk factors for death,
adverse clinical events, and adverse clinical events, or death.
Analyzed risk factors included: age; gender; NYHA functional
class; hypertension; pulmonary disease; cardiomegaly on chest
x-ray; prior cardiac surgery; degree of severity of valvular
regurgitation and stenosis for the mitral, aortic, and tricuspid
valves; degree of left and right ventricular dysfunction; degen-
erative valve disease; rheumatic valve disease; concomitant
aortic or mitral valvular surgery; use of valve repair or replace-
ment strategy for the mitral, aortic, and tricuspid valves; use of
an annuloplasty ring for tricuspid repair; concomitant coronary
artery bypass surgery; and the use of IOE. Logistic regression
was used to determine risk factors for surgical failure. Ana-
lyzed risk factors were identical to those analyzed for the Cox
regression models. The multivariable models were built in a
step-wise fashion with age and gender always included in each
model.
Results
Preoperative demographics and echocardiographic find-
ings. Preoperative study population demographics, frequen-
cies of comorbidities, and echocardiographic findings as dem-
onstrated on the preoperative echocardiogram are shown in
Table 1. The frequency of moderately severe to severe mitral
stenosis and moderately severe to severe aortic stenosis were
greater in the group who did not undergo IOE.
Types of tricuspid valve surgery and other concomitant
surgeries. The types of TV surgical procedures and other
concomitant surgeries performed are shown in Table 2. Other
less frequently performed TV procedures included commissur-
otomy, decalcification, and chordoplasty. Tricuspid valve an-
nuloplasty with a Carpentier-Edwards ring, TV annuloplasty
without an annuloplasty ring (suture annuloplasty), and mitral
valve replacement occurred more frequently in the study group
who did not undergo IOE. Tricuspid annuloplasty with a
Figure 2. Intraoperative color flow Doppler evaluation of tricuspid
valve dysfunction using transesophageal echocardiography demon-
strating: top, moderately severe (31) tricuspid regurgitation prior to
surgical repair; middle, severe (41) tricuspid regurgitation after first
repair effort; and bottom, mild (11) tricuspid regurgitation after a
second cardiopulmonary bypass run for a second and final repair effort.
1025JACC Vol. 32, No. 4 BAJZER ET AL.
October 1998:1023–31 TRICUSPID SURGERY AND INTRAOPERATIVE ECHO
PeriGuard ring, and mitral valve replacement, occurred more
frequently in the study group who did undergo IOE.
Immediate surgical outcome. The immediate surgical out-
come as determined by the use of IOE is shown in Figure 3.
Overall, 10% of preoperative surgical plans were altered based
on the findings of IOE with the goal of facilitating a successful
immediate surgical outcome for each patient.
Follow-up echocardiographic outcome. Findings at the
time of echocardiographic follow-up are shown in Table 3.
Echocardiographically defined failure of TV surgery occurred
in 52 (13%) of all patients undergoing TV surgery.
Risk of clinical end points. Results of multivariable anal-
yses of death, the occurrence of an adverse clinical event after
TV surgery, and the combined end point of death or the
occurrence of an adverse clinical event after TV surgery in the
401 study patients are shown in Figure 4. Increased relative
risk of death after TV surgery was independently associated
with a higher preoperative NHYA functional classification
(relative risk [RR] 2.02, 1.39–2.95; p , 0.001), increased
degree of left ventricular dysfunction on preoperative echo
(RR 1.28; 1.08–1.51, p 5 0.005), and with the use of a TV
replacement strategy (RR 2.92, 1.46–5.84; p 5 0.002). In-
creased RR of the occurrence of an adverse clinical event was
significantly associated with coronary artery bypass surgery
performed concomitantly with TV surgery (RR 2.97, 1.39–
6.36; p 5 0.005). Increased relative risk of death or the
occurrence of an adverse clinical event was associated with a
higher preoperative NYHA functional class (RR 1.91, 1.35–
2.68; p , 0.001), an increased degree of left ventricular
dysfunction on preoperative echo (RR 1.18, 1.01–1.39; p 5
0.039), the use of a TV replacement strategy (RR 3.33,
1.77–6.26; p , 0.001), and coronary artery bypass surgery
performed concomitantly with TV surgery (RR 1.52, 1.02–2.28;
p 5 0.042). Decreased relative risk of death or the occurrence
of an adverse clinical event was significantly associated with a
mitral valve replacement strategy performed concomitantly
with TV surgery (RR 0.70, 0.49–0.99; p 5 0.045) when both
valves were sufficiently dysfunctional to require surgical cor-
rection.
Risk of echo failure of tricuspid surgery. Results of multi-
variable analysis of echocardiographic failure of TV surgery
are shown in Figure 4. Increased odds ratio of echocardio-
graphic failure of TV surgery was significantly associated with
increased severity of TR on preoperative echo (OR 1.91,
1.27–2.88; p 5 0.002). A significant decreased relative risk of
echocardiographic failure of TV surgery was associated with
the use of a tricuspid annuloplasty ring with a repair strategy
(OR 0.40, 0.21–0.76; p 5 0.005).
Seven adverse clinical events occurred in the group of 52
patients that had echocardiographic failure of TV surgery: two
Table 1. Study Population Preoperative Demographics and Echo
Findings
Intraoperative
Echo
(n 5 335)
No
Intraoperative
Echo
(n 5 66)
p
Value
Demographics
Age
Median (range) 63 (45–70) 66 (40–72) 0.347
Gender
Female 237 (71%) 42 (64%) 0.251
Male 98 (29%) 24 (36%) 0.251
Pulmonary disease 224 (67%) 43 (65%) 0.787
EKG
Atrial fibrillation 3 (1%) 0 (0%) 0.436
L/R bundle branch block 35 (10%) 6 (9%) 0.739
L/R ventricular hypertrophy 56 (17%) 14 (21%) 0.379
Chest x-ray
Cardiomegaly 261 (78%) 56 (85%) 0.206
NYHA Functional Class
0 8 (2%) 1 (2%) 0.604
I 44 (13%) 5 (8%) 0.130
II 152 (45%) 29 (44%) 0.783
III 100 (30%) 19 (29%) 0.828
IV 28 (8%) 12 (18%) 0.051
Echo Findings
Moderately-severe to severe
(31 to 41):
Tricuspid regurgitation 259 (77%) 52 (80%) 0.634
Tricuspid stenosis 2 (1%) 1 (2%) 0.421
Mitral regurgitation 188 (56%) 32 (48%) 0.212
Mitral stenosis 41 (12%) 17 (26%) 0.004
Aortic regurgitation 27 (8%) 7 (11%) 0.473
Aortic stenosis 20 (6%) 11 (17%) 0.003
Left ventricular dysfunction 18 (5%) 5 (8%) 0.558
Right ventricular dysfunction 17 (5%) 3 (5%) 1.000
Table 2. Study Population Operative Characteristics
Intraoperative
Echo
(n 5 335)
No
Intraoperative
Echo
(n 5 66)
Between
Groups
p Value
Overall
p
Value
TV Repair — 0.064
Annuloplasty with ring 254 (76%) 47 (71%) 0.147 —
C.-E. ring 115 (34%) 35 (53%) 0.016 —
PeriGuard ring 137 (41%) 12 (18%) 0.001 —
Other ring 2 (1%) 0 (0%) 0.156 —
Annuloplasty without ring 44 (13%) 17 (26%) 0.039 —
Commissurotomy 11 (3%) 3 (5%) 0.699 —
Other 17 (5%) 1 (2%) 0.050 —
TV Replacement — —
St. Jude 6 (2%) 0 (0%) — —
C.-E. 3 (1%) 0 (0%) — —
MV surgery 289 (86%) 55 (83%) — 0.533
Repair 109 (33%) 9 (14%) 0.002 —
Replace 180 (54%) 46 (70%) 0.017 —
AV surgery 90 (27%) 21 (32%) — 0.411
Repair 12 (4%) 1 (2%) 0.386 —
Replace 78 (23%) 20 (30%) 0.142 —
PV surgery 1 (0%) 0 (0%) — 0.657
Repair 0 (0%) 0 (0%) — —
Replace 1 (0%) 0 (0%) 0.657 —
CABG 55 (16%) 14 (21%) 0.346 —
C.-E., Carpentier-Edwards.
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patients had return of original symptom(s) prompting surgery,
two patients had the occurrence of heart failure symptom(s),
and three patients required reoperation for symptomatic TV
dysfunction. However, echocardiographic failure of TV sur-
gery was not significantly associated with the occurrence of an
adverse clinical event after TV surgery (p 5 0.296).
Follow-up clinical outcome. Kaplan-Meier survival proba-
bility and event-free survival probability curves for the two
study population groups are shown in Figure 5. Eight-year
survival probability for the entire study population was 50%.
By analyzing the follow-up clinical data for the previously
specified adverse clinical events (death, recurrence of original
symptom(s) prompting surgery, occurrence of heart failure
symptom(s), reoperation for symptomatic TV dysfunction),
event-free survival probability was determined. Eight-year
event-free survival probability for the entire study population
was 40%.
Discussion
The clinical value and prognostic implications of data
obtained from preoperative and intraoperative echocardiogra-
phy in the surgical management of TV dysfunction was previ-
ously less well defined. This study identifies several clinical and
echocardiographic factors (NYHA functional class, left ven-
tricular dysfunction, TV replacement strategy, and concomi-
tant coronary artery bypass grafting) associated with an in-
creased risk of morbidity and mortality after TV surgery. The
severity of TR, determined by preoperative echocardiography,
was found to be predictive of the follow-up echocardiographic
outcome after TV surgery. Intraoperative echocardiography
provided information relevant to ensuring a successful imme-
diate echocardiographic outcome in 10% of TV surgical
procedures utilizing IOE.
Survival. The clinical and echocardiographic factors, cor-
rected for age and gender, independently associated in this
study with decreased survival after TV surgery include: in-
creased preoperative NYHA functional class, increased left
ventricular dysfunction on preoperative echo, and the use of a
TV replacement strategy. Previous studies have shown that
increased preoperative NYHA functional class is a risk factor
associated with increased mortality after TV surgery (1,2,4,6–
8). Similarly, increased left ventricular dysfunction has been
associated with increased mortality using invasive contrast
ventriculography to evaluate left ventricular function (10). The
finding that the use of a TV replacement surgical strategy was
associated with an increased relative risk of death was antici-
pated based on several prior reports, but contradicts some
previous reports (9,37). The overall 8-year survival of 50% is
lower than (38,41–43), equivalent to (44–46), and less than
(3,7,9,47) several previously reported values. Similar compar-
isons can be made with event-free survival. The overall survival
and event-free survival are, to a large extent, inherent descrip-
tors of the study population, in addition to reflecting the effects
of diagnostic and therapeutic interventions.
Event-free survival. An increased preoperative NYHA
functional class, increased left ventricular dysfunction on pre-
operative echo, the use of a TV replacement strategy, and
performance of concomitant coronary artery bypass surgery
are associated with a reduced event-free survival. These find-
ings are in excellent agreement with previous findings in this
study for death and clinical events alone, as well as previous
findings of other studies (1–7,9,10). Adverse clinical events
have been associated in previous studies with increased sever-
ity of TR on preoperative evaluation (1), the presence of
severe mitral valve dysfunction (3), the presence of severe right
ventricular dysfunction (5,7,9) and the presence of significant
Table 3. Study Population Postoperative Echo Findings
Intraoperative
Echo
(n 5 335)
No
Intraoperative
Echo
(n 5 66)
Overall
p Value
Moderately-Severe to Severe
(31 to 41):
Tricuspid regurgitation 43 (13%) 9 (14%) 0.825
Tricuspid stenosis 0 (0%) 0 (0%) —
Mitral regurgitation 20 (6%) 5 (8%) 0.578
Mitral stenosis 1 (0%) 0 (0%) 1.000
Aortic regurgitation 0 (0%) 1 (1%) 0.162
Aortic stenosis 1 (0%) 0 (0%) 1.000
Left ventricular dysfunction 36 (11%) 4 (6%) 0.135
Right ventricular dysfunction 28 (8%) 4 (6%) 0.569
Figure 3. Immediate outcome of valvular surgery
facilitated by the use of intraoperative echocardiogra-
phy.
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primary pulmonary disease (1). However, this study did not
confirm these previous findings.
Risk of echo failure of tricuspid valve surgery. Identifica-
tion by the present study of increased severity of TR on
preoperative echo as a risk factor for echocardiographic failure
of TV surgery represents a new finding. However, increased
severity of TR as determined by cardiac catheterization was
previously identified as a risk factor for increased mortality in
the setting of TV replacement surgery (1).
Clinical significance of echo failure of tricuspid valve
surgery. Controversy exists over the clinical significance of the
demonstration of echocardiographic failure after TV surgery.
One study has demonstrated that the occurrence of severe,
symptomatic TR late after mitral valve replacement is associ-
ated with right ventricular failure and portends a poor prog-
nosis (48). In addition, the surgical repair of significant TR late
after mitral valve replacement did little to improve survival,
and TV surgery was recommended to be performed at the time
of the original mitral valve surgery, if significant TR was
present (48). In our study, right ventricular function evaluated
preoperatively was not significantly associated with an in-
creased relative risk for death, adverse clinical event, or
echocardiographic failure of TV surgery. Significant, grade 31
or 41, TR has been shown by several authors to be a negative
prognostic factor if not surgically corrected (1,5,37,48,49). It
appears logical that echocardiographic failure of TV surgery
would be associated with an increased risk of death or the
occurrence of an adverse clinical event. In our study, however,
no significant association was demonstrated between the pres-
ence of echocardiographic failure of TV surgery and death
after TV surgery (p 5 0.183). Similarly, two previous studies
(42,43) have demonstrated no relation between the presence
of significant TR after TV replacement surgery and the
occurrence of adverse clinical symptoms.
Figure 4. Relative risk of death, adverse clinical event, death or
adverse clinical event, and odds ratio of echocardiographic failure after
tricuspid valve surgery.
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Type of tricuspid valve surgery. In this study TV repair
strategies predominated, and the use of an annuloplasty ring
with a repair strategy was associated with a significant de-
creased relative risk of echocardiographic failure of TV sur-
gery. This leads us to conclude, along with previous authors
(8,50), that an annuloplasty ring with a repair strategy is a
preferable method of correcting TV dysfunction, when techni-
cally feasible.
Concomitant coronary artery bypass grafting. The perfor-
mance of concomitant coronary artery bypass grafting was
identified as an independent risk factor for decreased event-
free survival associated with TV surgery. A previous study (2)
had identified the presence of coronary artery disease as an
independent risk factor for death in TV replacement with a
CarboMedics prosthetic valve. Other authors have shown that
combined valve operations and coronary artery bypass grafting
have a higher risk of death than either procedure performed
alone (51–53).
Concomitant mitral valve surgery. Interestingly, a mitral
valve replacement strategy to correct significant mitral valve
dysfunction used concomitantly with TV surgery to correct
significant TV dysfunction was independently associated with a
decreased relative risk of the combined end point of death or
the occurrence of an adverse clinical event after TV surgery. In
contrast, mitral valve surgery in general, or a mitral valve
repair strategy in specific, performed concomitantly with TV
surgery when both were indicated to correct significant valvular
dysfunction, were not significantly associated with a decreased
or increased relative risk of the combined endpoint of death or
the occurrence of an adverse clinical event after TV surgery.
When both the mitral and tricuspid valves are sufficiently
dysfunctional to both require surgery, replacement of the
mitral valve and repair of the TV with the use of an annulo-
plasty ring is the surgical strategy associated with the most
favorable outcome.
Benefit of intraoperative echo. This study demonstrated an
objective benefit of the use of IOE on the immediate outcome
of TV and other cardiac valvular surgery. The use of IOE in
TV and other cardiac valve surgery prevented a significant
number of patients from leaving the operating room with
either undiscovered or inadequately corrected valve dysfunc-
tion that could have translated to an increased postoperative
morbidity and mortality (48).
Our study failed to demonstrate a significant association of
either benefit or detriment with the use of IOE and the
observed outcome of TV surgery with respect to mortality,
echocardiographic failure of TV surgery, the occurrence of an
adverse clinical event, or the combined end point of death or
the occurrence of an adverse clinical event. This may be due to
an inadequate sample size to detect such an association, or that
comorbidities such as left ventricular dysfunction, coronary
artery disease, and the progression of underlying valvular
pathology are the dominant determinants of long-term out-
comes.
Limitations. A surgical bias existed against the use of
intraoperative echo in the setting of significant concomitant
mitral or aortic stenosis when a valve replacement strategy was
frequently planned. A second surgical bias favored the use of
intraoperative echo in the setting of a mitral valve repair
strategy. The limitations of this study include the surgical bias
and the inherent bias and limitations associated with a cohort
study. Conclusive demonstration of an association of signifi-
cant benefit or detriment with the use of IOE and outcomes of
TV or other cardiac valvular surgery would require a large
longitudinal randomized, controlled trial. In the absence of
such a trial, cohort studies with large patient numbers, such as
this one, provide limited surrogate information toward dem-
onstrating the benefit of the use of IOE in facilitating success-
ful outcomes after TV surgery.
Conclusions. This study identified clinical and echocardio-
graphic factors associated with adverse clinical and echocar-
diographic outcomes after TV surgery. The use of a TV
annuloplasty ring with a repair strategy was associated with the
most favorable clinical and echocardiographic outcomes. This
study was unable to determine whether changes in the surgical
plan made based on data from IOE conferred any advantage to
the patient in terms of clinical or echocardiographic outcomes
beyond the time of surgery. However, the benefit of IOE on
the outcome of TV surgery was in identifying previously
unrecognized TV dysfunction requiring surgery and in identi-
fying an unsatisfactory first attempt at surgical correction of a
Figure 5. Top, Kaplan-Meier survival probability, and bottom, event-
free survival probability after surgery to correct a dysfunctional
tricuspid valve.
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dysfunctional TV in order to facilitate the patient leaving the
operating room with the best possible surgical corrective
procedure.
We thank the employees of the Cleveland Clinic Foundation Cardiovascular
Information Registry (CVIR) for their diligent work in abstracting charts and
performing follow-up interviews, which were invaluable to the completion of this
study.
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